星形胶质增生
淀粉样前体蛋白
胶质纤维酸性蛋白
细胞生物学
神经炎症
星形胶质细胞
生物
神经科学
化学
炎症
免疫学
阿尔茨海默病
中枢神经系统
医学
病理
免疫组织化学
疾病
作者
Gretsen Velezmoro Jáuregui,Dragana Vukić,Isaac G. Onyango,Carlos Arias,Jan Novotný,Kateřina Texlová,Shanshan Wang,Kristína Kovačovicová,Natalie Polakova,Jana Zelinková,Mária Čarná,Valentina Lacovich,Brian P. Head,Daniel Havas,Martin Mistrík,Robert Zorec,Alexei Verkhratsky,Liam P. Keegan,Mary A. O’Connell,Robert A. Rissman
摘要
Abstract Aim Astrocytes respond to stressors by acquiring a reactive state characterized by changes in their morphology and function. Molecules underlying reactive astrogliosis, however, remain largely unknown. Given that several studies observed increase in the Amyloid Precursor Protein (APP) in reactive astrocytes, we here test whether APP plays a role in reactive astrogliosis. Methods We investigated whether APP instigates reactive astroglios by examining in vitro and in vivo the morphology and function of naive and APP‐deficient astrocytes in response to APP and well‐established stressors. Results Overexpression of APP in cultured astrocytes led to remodeling of the intermediate filament network, enhancement of cytokine production, and activation of cellular programs centered around the interferon (IFN) pathway, all signs of reactive astrogliosis. Conversely, APP deletion abrogated remodeling of the intermediate filament network and blunted expression of IFN‐stimulated gene products in response to lipopolysaccharide. Following traumatic brain injury (TBI), mouse reactive astrocytes also exhibited an association between APP and IFN, while APP deletion curbed the increase in glial fibrillary acidic protein observed canonically in astrocytes in response to TBI. Conclusions The APP thus represents a candidate molecular inducer and regulator of reactive astrogliosis. This finding has implications for understanding pathophysiology of neurodegenerative and other diseases of the nervous system characterized by reactive astrogliosis and opens potential new therapeutic avenues targeting APP and its pathways to modulate reactive astrogliosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI